So Jeong Lee's profile photo

So Jeong Lee

Featured in: Favicon wiley.com Favicon mdpi.com Favicon acs.org Favicon diabetesjournals.org Favicon thefinancialexpress.com.bd Favicon onlinelibrary.wiley.com Favicon pubs.acs.org Favicon diabetes.diabetesjournals.org

Articles

  • Development and validation of long-acting recombinant human TSH using SAFA technology

    Feb 17, 2025 | erc.bioscientifica.com | So Jeong Lee |Yoon Cho |Daham Kim |Gunuk Zi

    Keywords: neonatal Fc receptor; radioiodine therapy; recombinant proteins; thyroid neoplasms; thyrotropinIntroductionThyroid cancer is the most common endocrine malignancy and differentiated thyroid cancer (DTC) accounts for >90% of all thyroid cancers (Choi et al. 2022, Kitahara & Schneider 2022). The primary treatment for patients with DTC is surgery, followed by radioactive iodine (RAI) therapy, when indicated, and thyroid hormone suppression therapy (Lee et al. 2024a,b, Ryu et al. 2024).

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →